In a recent article, [@b3-ehp0114-a0274a] reported the first study of the clinical toxicity of dimethylamine borane (DMAB) poisoning, particularly the neurologic manifestations in the central nervous system and peripheral nervous system. They decribed a prominent cerebellar dysfunction including impairments in performing tandem gait, finger-to-nose, and heel-to-knee tests and slurred speech in one patient who had the most severe neurologic symptoms 3 days after DMAB intoxication. We had the opportunity to evaluate the same patient 1 month after DMAB intoxication ([@b1-ehp0114-a0274a]). Neurologic examinations revealed no cerebellar signs. Although [@b3-ehp0114-a0274a] reported that brain magnetic resonance images (MRI) showed a symmetric increase in signal intensity at the bilateral cerebellar periventricular areas on 9 February 2004, the follow-up brain MRI study in our hospital 6 weeks after intoxication showed a nearly normal result. However, [@b3-ehp0114-a0274a] interpreted that the rapid recovery of brain MRI changes may be due to a transient demyelination, axonal degeneration, or neuronal damages. This phenomenon is best interpreted as a transient brain edema. In addition to the transient edema, the other possibility is that the high signal intensity in cerebellar dentate nuclei is caused by an artifact. Therefore, a series section of the brain MRI images is required.

Six weeks after DMAB exposure, we found that the patient was still confused about time ([@b1-ehp0114-a0274a]). Fourteen weeks after exposure, a neuropsychological study revealed that he had a cognitive impairment in learning ability of verbal and nonverbal learning memory; attention functions including focus, tracking, and divided attention; working memory; and semantic category retrieval. The data suggested that a prolonged toxic effect of the DMAB on the central nervous system still persisted in the attention, personality, and memory function.

The patient developed a progressive distal numbness and limb weakness 5 days after DMAB intoxication, and neurologic examinations showed generalized hyporeflexia; decreased sensation in pin-prick, temperature, touch, vibration, and position sensations; and weakness in the distal limbs, particularly in both feet ([@b1-ehp0114-a0274a]). The data were further supported by sural nerve biopsy and cutaneous nerve biopsy studies ([@b1-ehp0114-a0274a]). Our serial nerve conduction studies also confirmed axonal polyneuropathy, particularly in the motor nerves. However, [@b3-ehp0114-a0274a] stated that the polyneuropathy with axonal polyneuropathy was verified by serial electroencephalogram and nerve conduction velocity studies.

Our time course of DMAB-induced polyneuropathy indicated an acute axonal polyneuropathy ([@b1-ehp0114-a0274a]). However, [@b3-ehp0114-a0274a] misdiagnosed the patient as having a delayed polyneuropathy, which may be wrong, because the time course was different from the so-called "delayed polyneuropathy" induced by organophosphate intoxication (Senanyake and Karalliedde 1987).
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